(HealthDay)—Fifty-five percent of children, adolescents, and young adults with hematologic malignancies experience high-intensity end-of-life care (HI-EOLC), with an increased likelihood for those treated at medium
Read more
Home »
(HealthDay)—Fifty-five percent of children, adolescents, and young adults with hematologic malignancies experience high-intensity end-of-life care (HI-EOLC), with an increased likelihood for those treated at medium
Read moreScreening and the HPV vaccine have led to drops in cervical cancers over the last two decades in the U.S., a new study finds, but
Read moreA new technique that can trace which tissues and organs the DNA in our blood comes from has been reported today in the open-access eLife
Read moreIn addition to lowering risk of heart disease, maintaining a heart-healthy lifestyle may pay off in lower risk for developing cancer, researchers from Massachusetts General
Read moreInsofar as the war on cancer used to be fought by surgical strikes, chemical warfare and nuclear bombardment, today’s and tomorrow’s cancer battles are fought
Read moreProAgio, a drug developed by Georgia State University biology professor Zhi-Ren Liu and his team, is effective at treating pancreatic cancer and prolonging survival in
Read more(HealthDay)—Regular aspirin use is associated with a lower risk for colorectal and other digestive tract cancers, according to a review published in the May 1
Read moreOver the last two decades, there has been a rise in head and neck cancers in the oropharynx, a region in the back of the
Read moreThe basic unit of all living things is the cell—and the human body contains tens of trillions of them. Cancer can be triggered by the
Read moreAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.
Read more